Sulzberger Gabrielle — SEC Form 4 filings
SEC reporting owner CIK 1262388. 39 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2024-01-17 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 117 shares, $75,018 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: purchase of 117 shares @ $641.18 ($75,018) in ELI LILLY & Co, filed 2025-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ELI LILLY & Co (LLY) | Director | 33 | 1 leg · 117 sh · $75,018 | — | 34 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | Director | 2 | — | — | 4 |
| Mastercard Inc (MA) | Director | 3 | — | — | 3 |
| Warby Parker Inc. (WRBY) | Director | 1 | — | — | 1 |
Form 4 filings — Sulzberger Gabrielle
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.19 @ $1,183.16 | EDGAR |
| 2026-07-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.32 @ $1,146.90 | EDGAR |
| 2026-06-18 | 4 | Mastercard Inc (MA) | Grant/award (A): 509 @ $0 | EDGAR |
| 2026-06-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.39 @ $1,129.35 | EDGAR |
| 2026-05-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 5.02 @ $988.09 | EDGAR |
| 2026-04-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 5.39 @ $919.90 | EDGAR |
| 2026-03-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 5.01 @ $989.12 | EDGAR |
| 2026-02-18 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.79 @ $1,036.05 | EDGAR |
| 2026-01-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.76 @ $1,041.29 | EDGAR |
| 2025-12-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.67 @ $1,062.19 | EDGAR |
| 2025-11-18 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 4.85 @ $1,021.70 · Grant/award (A): 215.33 @ $1,021.70 | EDGAR |
| 2025-10-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.13 @ $808.96 | EDGAR |
| 2025-09-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.63 @ $748.19 | EDGAR |
| 2025-08-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 7.10 @ $698.05 | EDGAR |
| 2025-08-12 | 4 | ELI LILLY & Co (LLY) | Purchase (P): 117 @ $641.18 | EDGAR |
| 2025-07-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.50 @ $762.18 | EDGAR |
| 2025-06-26 | 4 | Mastercard Inc (MA) | Grant/award (A): 458 @ $0 | EDGAR |
| 2025-06-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.14 @ $807.58 | EDGAR |
| 2025-05-20 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.57 @ $755.11 | EDGAR |
| 2025-04-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.06 @ $818.02 | EDGAR |
| 2025-03-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.01 @ $824.76 | EDGAR |
| 2025-02-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 5.78 @ $857.20 | EDGAR |
| 2025-01-23 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 6.68 @ $742.35 | EDGAR |
| 2024-12-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 12.73 @ $779 | EDGAR |
| 2024-11-20 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13.64 @ $727.20 · Grant/award (A): 302.53 @ $727.20 | EDGAR |
| 2024-10-22 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $906.13 | EDGAR |
| 2024-09-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $923.54 | EDGAR |
| 2024-08-20 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $921.81 | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 48,415 · Disposition to issuer (D): 10,461 · Disposition to issuer (D): 95,242 (derivative) | EDGAR |
| 2024-07-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 10 @ $950.46 | EDGAR |
| 2024-06-21 | 4 | Mastercard Inc (MA) | Grant/award (A): 545 @ $0 | EDGAR |
| 2024-06-18 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 11 @ $885.01 | EDGAR |
| 2024-06-11 | 4 | Warby Parker Inc. (WRBY) | Grant/award (A): 14,793 @ $0 | EDGAR |
| 2024-06-07 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 10,461 | EDGAR |
| 2024-05-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $783.18 | EDGAR |
| 2024-04-16 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $750.77 | EDGAR |
| 2024-03-19 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $762.66 | EDGAR |
| 2024-02-21 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 13 @ $755.66 | EDGAR |
| 2024-01-17 | 4 | ELI LILLY & Co (LLY) | Grant/award (A): 16 @ $634.57 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1262388 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →